Buy REVOFIL ULTRA Online

Revofil Ultra is a highly viscous dermal filler formulated with cross-linked hyaluronic acid and bioactive peptides for the treatment of deep wrinkles and facial contouring. This product is designed to provide long-lasting volume restoration and enhance facial contours by adding fullness to areas such as the cheeks, chin, and jawline. Revofil Ultra is known for its ability to maintain its structure and longevity in the skin, making it ideal for deep tissue augmentation.

The filler combines cross-linked hyaluronic acid with free HA and CG-Boostrin peptides, which work together to enhance collagen synthesis and prolong the effect of the filler, making it durable and effective over an extended period.

Revofil Ultra Indications for Use

Revofil Ultra is indicated for:

• Correction of deep wrinkles such as nasolabial folds and marionette lines.
• Facial contouring in areas like the cheeks, chin, jawline, and temples.
• Volume restoration in the mid-face, particularly in patients with volume loss due to aging.
• Lip lifting and augmentation for patients requiring added definition or fullness.

Target Areas:

• Nasolabial folds, forehead, cheeks, chin, and jawline.
• Marionette lines, and areas that require volume enhancement such as the mid-face and temples.

Revofil Ultra Dosage Information

• Each pre-filled syringe contains 1 ml of Revofil Ultra, with a hyaluronic acid concentration of 23 mg/ml.
• Injection depth: Revofil Ultra is designed for deep tissue injections, primarily targeting the mid-dermis to subcutaneous layers.
• Needle size: A 27G needle is recommended for the injection process, ensuring precision and patient comfort.

Treatment Frequency:

• Results can last on average 12 months, depending on the area treated and the patient’s skin type. Touch-up treatments may be scheduled as needed to maintain optimal results.

Revofil Ultra Side Effects and Precautions

Like other dermal fillers, Revofil Ultra may cause minor, temporary side effects that generally resolve within a few days. Common side effects include:

• Redness, swelling, or bruising at the injection site.
• Mild discomfort or itching immediately after treatment.
• Rare complications may include infection, nodules, or hypersensitivity reactions.

Precautions:

• Avoid treatment in patients with severe allergies, autoimmune diseases, or those undergoing immunosuppressive therapy without prior consultation with a healthcare provider.
• The filler should not be used on pregnant or breastfeeding women.
• Avoid injecting into areas with active inflammation, acne, or skin infections.

Patients should be advised to avoid intense physical activity, sun exposure, and extreme heat for at least 24-48 hours following treatment.

Revofil Ultra Clinical Studies and Outcomes

Revofil Ultra has shown exceptional results in both deep wrinkle correction and volume enhancement. In clinical studies, patients experienced long-lasting improvements in facial volume and contour, with enhanced skin elasticity due to the bioactive peptides and hyaluronic acid.

Key Findings:

• 81% increase in collagen synthesis and 45% increase in hyaluronic acid production, leading to firmer, more youthful skin.
• 90% reduction in hyaluronidase activity, which slows the degradation of hyaluronic acid in the skin, contributing to the filler’s extended lifespan.

Patient Satisfaction: Clinical trials reported 99% satisfaction among patients treated with Revofil Ultra, with significant improvements in the appearance of deep wrinkles and facial volume that lasted for up to 12 months.

Case Example: A patient in her 30s treated with Revofil Ultra for nasolabial folds and forehead augmentation saw remarkable improvements in facial fullness and wrinkle reduction after six months, with effects sustained for a year before a touch-up was required.

Revofil Ultra Drug Interactions

No significant drug interactions have been reported with Revofil Ultra. However, caution should be exercised with patients taking anticoagulants or blood thinners such as aspirin or NSAIDs, as they may increase the risk of bruising or bleeding at the injection site.

Patients should disclose any medications they are taking to their healthcare provider prior to treatment.

Revofil Ultra Application Instructions

Revofil Ultra should only be injected by trained medical professionals using aseptic techniques to ensure the safety and effectiveness of the procedure.

Procedure:

1. Cleanse the treatment area thoroughly to minimize the risk of infection.
2. Inject Revofil Ultra using a 27G needle into the appropriate dermal layer, depending on the treatment area and desired outcome.
3. Massage the treated area gently to distribute the product evenly after injection.
4. Aftercare includes applying cold compresses to reduce swelling and advising patients to avoid massaging or rubbing the treated area.

Revofil Ultra Storage and Handling

Revofil Ultra should be stored between 2°C and 25°C, protected from direct sunlight and freezing temperatures. Once opened, the syringe must be used immediately and should not be reused to prevent contamination or infection.